Related Experiment Video
Updated: Aug 11, 2026
A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets
Published on: December 5, 2014
Attentional effects of single dose triazolam
C S Carter1, R Maddock, M Chaderjian
1Department of Psychiatry, University of Pittsburgh, PA, USA. cscarter+@pitt.edu
Triazolam, a benzodiazepine, selectively impacts automatic visual-spatial attention by enhancing target detection. This study highlights the drug's specific effects on exogenous attentional processes.
Area of Science:
- Neuroscience
- Psychopharmacology
Background:
- Benzodiazepines are well-studied for memory effects, but their impact on attention remains less understood.
- Selective visual-spatial attention is crucial for cognitive function.
Purpose of the Study:
- To investigate the effects of a single dose of triazolam on selective visual-spatial attention.
- To differentiate the drug's influence on automatic (exogenous) versus controlled (endogenous) attentional processes.
Main Methods:
- A double-blind, placebo-controlled study involving 12 healthy volunteers.
- Administration of 0.25 mg triazolam or placebo across two sessions.
- Utilized covert orienting paradigms to assess exogenous and endogenous attention.
Main Results:
- Triazolam selectively altered performance in automatic orienting to exogenous cues.
- Observed increased facilitation of target detection at shorter stimulus-onset asynchronies (SOAs) after triazolam administration.
- Potential implications include enhanced facilitation, reduced inhibition, or altered temporal dynamics of exogenous attentional effects.
Conclusions:
- Triazolam specifically affects automatic attentional orienting mechanisms.
- Emphasizes the need for experimental designs that distinguish between endogenous and exogenous attentional processes when studying pharmacological agents.
More Related Videos
07:54Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test
Published on: June 29, 2018
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
01:14CNS Depressants: Barbiturates and Benzodiazepines
01:26Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
01:23Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...